Get the full Orano Med company profile
Access contacts, investors, buying signals & more
Orano Med, a company developing new cancer treatments based on radioactive isotopes, has secured $142.7M in funding from the European Investment Bank (EIB).
The investment comes as Orano Med continues its work with high-purity lead-212 (Pb-212), a rare radioactive isotope. This isotope is at the heart of its targeted alpha therapy (TAT) approach, which aims to recognize and destroy cancer cells while limiting impact on healthy tissue. The company's R&D program for Pb-212 began in 2005.
⚕️ 3 financing rounds and 4 M&A in Med & Health Tech this week 👇 💶 Startup Funding En Carta Diagnostics €5M led by Blue Forest Ventures with Ring Capital, CentraleSupélec Venture, 50 Partners Health, #angels and Bpifrance | Diagnostics: at home molecular te
sting for Lyme disease and STIs 👏🚀 Leo Cancer Care $65M Series D | Oncology - proton radiotherapy Orano Med €125M from EIB | Oncology - radiopharmaceuticals manufacturing & targeted alpha therapy 📈 M&A, IPO & Strategic Deals Stereotaxis acquires Robocath for up to $45M | Robotics - endovascular intervention Frazier Healthcare Partners acquires Resmed's MatrixCare for $490M | Digital health
En Carta Diagnostics
Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.
$5.5M Seed
today
naaia.ai
Naaia provides a leading BtoB SaaS platform to manage AI risks & compliance for public and private organisations. Through an end-to-end, multi regulatory & multi framework approach, Naaia ensures the accelerated implementation of trusted AI.
$6.8M Series a
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 1y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Solaris Endovascular United States | Unknown | $5.0M | today |
| 2 |  Proxima United States | Unknown | $445.0M | today |
Green Hub
Notre mission : accélérer la transition énergétique en soutenant le développement des marchés environnementaux et en facilitant l’accès à la liquidité et au financement durable pour les entreprises engagées. Green Hub agit au cœur de ces nouveaux écosystèmes où l’économie et le climat se rejoignent — en contribuant à structurer, valoriser et dynamiser les produits environnementaux qui soutiennent la décarbonation. Au-delà des marchés, nous portons une conviction : la performance économique et la responsabilité environnementale sont désormais indissociables.
$12.8M Series a
3 days ago
| $7.2B |
| 1y ago |
| 3 |  Illumina United States | Unknown | $7.1B | 1y ago |
| 4 |  GRAIL United States | Unknown | $7.1B | 1y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 6mo ago |
| 3 |
 Vooban Canada |
| Unknown |
| $1.8M |
| today |
| 4 |  League Canada | Unknown | $3.0M | today |
| 5 |  AlayaCare Canada | Unknown | $2.9M | today |
Trusted by 200+ sales teams
EIB
DEVELOPMENT BANK
Reach Orano Med's investors directly from your dashboard.
Start free trialFrédéric D.
Chief Executive Officer
Anne-Sophie B.
VP, General Counsel Competition and Innovation
Unlock 8 more key decision-makers at Orano Med with verified emails and LinkedIn.
Start free trial
Supply6
Recently received
Alchemab Therapeutics Ltd
Recently received
Insight Medbotics
Recently received
